|
Celgene (US1510201049)
BSN News mit im "Celgene" im Titel >> Zum News-Archiv
21.11.2019
wikifolio whispers p.m. zu Uniper; Rheinmetall; Advanced Micro Devices, Inc.; Biofrontera; Celgene; Wirecard; JinkoSolar; CTS E...
21.11.2019
wikifolio whispers a.m.: CTS Eventim, Petro Welt Technologies, Wirecard, K+S, Celgene, Tesla, LPKF Laser, Volkswagen Vz. und Intel
20.11.2019
CELGENE ERHÄLT DIE ZULASSUNGSEMPFEHLUNG DES CHMP FÜR LENALIDOMID (REVLIMID®) IN KOMBINATION MIT RITUXIMAB ZUR BEHANDLUNG VON ER...
13.11.2019
wikifolio whispers a.m.: Advanced Micro Devices, Inc.; Rheinmetall; Deutsche Wohnen; Sixt; Nordex; Walt Disney; Alibaba Group H...
15.07.2019
wikifolio whispers p.m. zu Celgene, Carl Zeiss Meditec, Siemens, Airbus Group, Steinhoff, Deutsche Bank, Novo Nordisk, voestalp...
05.06.2019
Evotec erhält 9 Mio. Dollar von Celgene
28.05.2019
CELGENE ERHÄLT ZULASSUNGEN DER EUROPÄISCHEN KOMMISSION FÜR LENALIDOMID (REVLIMID®)- UND POMALIDOMID (IMNOVID®)-BASIERTE TRIPLET...
01.04.2019
wikifolio whispers p.m. zu Sixt, Celgene, Dialog Semiconductor, TUI AG, Nordex, publity, Gilead Sciences, Lufthansa, Airbus Gro...
31.03.2019
CELGENE ERHÄLT ZULASSUNGSEMPFEHLUNGEN DES CHMP FÜR AUF LENALIDOMID (REVLIMID®) UND POMALIDOMID (IMNOVID®) BASIERENDEN TRIPLETT-...
28.02.2019
wikifolio whispers a.m. Evotec, Celgene, QSC, TUI AG, SFC Energy, Infineon, Rio Tinto, Zurich Insurance und Nordex
» ytd | » Eine Woche | » Ein Monat | » Drei Monate | » 12 Monate | » 2013 | » 2014 | » 2015 | » 2016 | » 2017 | » 2018 | » 2019 | » 2020 | » 2021 | » 2022 | » 2023 |
der Periode wählen
Anzahl Handelstage einstellen
0 %
Das ist der 0. beste von 0 Handelstagen (%-Perf.)
Tage Steigend/Fallend
Periodenhoch am 20.11.2019 (Kurs: Δ% 0)
Periodentief am 20.11.2019 (Kurs: Δ% 0)
Durchschnittsperformance Wochentag
Best/Worst Days
finanzmarktmashup.at News
14.02.2020
The Rainmakers: Meet the top 20 bankers that orchestrated the biggest deals of 2019 and nabbed hu...
The largest mergers and acquisitions are team efforts, but at the very top, a battled-tested seni...
06.02.2020
Bristol-Myers: Celgene-Übernahme zahlt sich aus
Bristol-Myers: Celgene-Übernahme zahlt sich aus
27.01.2020
Bristol-Myers Squibb is planning to launch 8 drugs in 18 months for everything from cancer to mul...
The newly combined Bristol-Myers Squibb and Celgene is shaping up to be a formidable company in t...
07.01.2020
These are the top surprises that could rock biotech stocks, from a Gilead comeback to an unexpect...
2020 could bring a lot of surprises for biotech companies — both good and bad.In a December...
21.11.2019
A secretive $120 billion hedge fund has bested Warren Buffett again and again. These are its 10 b...
A secretive $120 billion hedge fund founded by a Cold War codebreaker has vastly outperformed War...
26.08.2019
Stocks surge as Trump calms investor fears over his trade war with China
Stocks rose on Monday after President Trump said China wants to return to the negotiating table t...
26.08.2019
Amgen will buy a blockbuster psoriasis drug for $13.4 billion — and it's part of a plan to get Ce...
Amgen will buy Otezla, Celgene's flagship psoriasis drug, for $13.4 billion — or about $11....
26.08.2019
Bei Celgene geht es um Milliarden
Bei Celgene geht es um Milliarden
15.08.2019
These 28 biotech startups have attracted the most VC cash, making them prime candidates for an ac...
Venture-capital money flowing into biotech over the past few years has led to record levels of pr...
19.07.2019
Here's why Gilead should buy a key asset from Celgene, as long as it can strike a deal for less t...
Bristol-Meyers Squibb struck a $74 billion deal in January to acquire the drug company Celgene.&n...
Social Trades
| 20.11.2019 |
OJE2013 Biotechnologie Chancen |
7 Stück zu 97.35 (sell - Gain: 20.86% ) |
| 20.11.2019 |
ROGO79 ROGO US Value |
13 Stück zu 97.54 (sell - Gain: 61.69% ) |
| 20.11.2019 |
Goldkoenig Defensiv mit Potenzial |
20 Stück zu 97.48 (sell - Gain: 24.5% ) |
| 20.11.2019 |
Pitjupp Hebelhilfe |
1 Stück zu 97.28 (buy) |
Die letzten 20 Tage der Periode
Chart
THGM | 17DIVPFL
Aktien-, ETF- & Fonds-Werte
Storch | MERGARB
Merger Arbitrage Chancen
schalhans | IBWW2020
Index Builder Wachstumswert...
schalhans | IBWW2020
Index Builder Wachstumswert...
Whitelog | HDV58768
Highly diversed Value